View in EDS HTML Full Text PDF Full Text

Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor.

Saved in:
Bibliographic Details
Title: Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor.
Authors: Schneeweiss MC; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Wyss R; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Anand P; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Jin Y; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Mostaghimi A; Harvard Medical School, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Barbieri JS; Harvard Medical School, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Associate Editor, JAMA Dermatology., Merola JF; Division of Rheumatology, Department of Dermatology and Department of Medicine, UT Southwestern Medical Center and O'Donnell School of Public Health, Dallas, Texas., Silverberg JI; Department of Dermatology, George Washington University, Washington, DC., Rosmarin DM; Department of Dermatology, Indiana University, Indianapolis., Glynn RJ; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Schneeweiss S; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Source: JAMA dermatology [JAMA Dermatol] 2026 Mar 01; Vol. 162 (3), pp. 313-316.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41563775
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schneeweiss+MC%22">Schneeweiss MC</searchLink>; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Wyss+R%22">Wyss R</searchLink>; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Anand+P%22">Anand P</searchLink>; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Jin+Y%22">Jin Y</searchLink>; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Mostaghimi+A%22">Mostaghimi A</searchLink>; Harvard Medical School, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Barbieri+JS%22">Barbieri JS</searchLink>; Harvard Medical School, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Associate Editor, JAMA Dermatology.<br /><searchLink fieldCode="AU" term="%22Merola+JF%22">Merola JF</searchLink>; Division of Rheumatology, Department of Dermatology and Department of Medicine, UT Southwestern Medical Center and O'Donnell School of Public Health, Dallas, Texas.<br /><searchLink fieldCode="AU" term="%22Silverberg+JI%22">Silverberg JI</searchLink>; Department of Dermatology, George Washington University, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Rosmarin+DM%22">Rosmarin DM</searchLink>; Department of Dermatology, Indiana University, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Glynn+RJ%22">Glynn RJ</searchLink>; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Schneeweiss+S%22">Schneeweiss S</searchLink>; Dermato-Pharmacoepidemiology Program, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589530%22">JAMA dermatology</searchLink> [JAMA Dermatol] 2026 Mar 01; Vol. 162 (3), pp. 313-316.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589530 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6084 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686068%22">21686068 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Dermatol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41563775
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamadermatol.2025.5443
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 313
    Titles:
      – TitleFull: Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schneeweiss MC
      – PersonEntity:
          Name:
            NameFull: Wyss R
      – PersonEntity:
          Name:
            NameFull: Anand P
      – PersonEntity:
          Name:
            NameFull: Jin Y
      – PersonEntity:
          Name:
            NameFull: Mostaghimi A
      – PersonEntity:
          Name:
            NameFull: Barbieri JS
      – PersonEntity:
          Name:
            NameFull: Merola JF
      – PersonEntity:
          Name:
            NameFull: Silverberg JI
      – PersonEntity:
          Name:
            NameFull: Rosmarin DM
      – PersonEntity:
          Name:
            NameFull: Glynn RJ
      – PersonEntity:
          Name:
            NameFull: Schneeweiss S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6084
          Numbering:
            – Type: volume
              Value: 162
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: JAMA dermatology
              Type: main
ResultId 1